Literature DB >> 8658061

Characterization of Haemophilus influenzae isolates from the respiratory tract of patients with primary antibody deficiencies: evidence for persistent colonizations.

A Samuelson1, S Borrelli, R Gustafson, L Hammarström, C I Smith, J Jonasson, A A Lindberg.   

Abstract

A total of 117 consecutive patients with primary antibody deficiencies were followed for up to 5 years with regard to acute respiratory tract infections. Nontypeable Haemophilus influenzae (NTHI) was the sole pathogen in 61% (202/330) of the samples from which a potential pathogen was recovered. Common variable immunodeficiency (CVI) was the most prevalent condition (27/39 patients) in the group where H. influenzae was isolated. In patients where H. influenzae was not found only 9/78 patients had CVI. 49 of these 78 patients had isolated IgG3 or IgA deficiency. Both of these entities seemed to be associated with a lower prevalence of NTHI infections. 13 of 18 patients with at least 2 isolates of NTHI were colonized with the same strain from 3 to 43 months as shown by total genomic DNA-fingerprinting. Recurrent symptomatic infections occurred in these patients despite substitution therapy with gammaglobulins and repeated antibiotic treatments. All but 2 of the 224 H. influenzae isolates were beta-lactamase negative and sensitive to ampicillin. The use of 10 lipopolysaccharide-specific monoclonal antibodies in a whole cell ELISA showed that the LPS-epitopes on the 224 H. influenzae isolates from the hypogammaglobulinemic group were very similar to 499 NTHI isolates from immunocompetent patients with respiratory infections. One may therefore conclude that i) patients with CVI, were prone to be permanently colonized with NTHI, and ii) the colonizing bacteria were ordinary strains showing the same LPS-phenotypes as those strains that cause acute respiratory tract infections in immunocompetent individuals.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8658061     DOI: 10.3109/00365549509032722

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  9 in total

Review 1.  Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID).

Authors:  L Hammarström; I Vorechovsky; D Webster
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

2.  Serum intercellular adhesion molecule 1 variations in young children with acute otitis media.

Authors:  Keyi Liu; Janet Casey; Michael Pichichero
Journal:  Clin Vaccine Immunol       Date:  2010-10-06

3.  Systemic humoral immunity to non-typeable Haemophilus influenzae.

Authors:  P T King; J Ngui; D Gunawardena; P W Holmes; M W Farmer; S R Holdsworth
Journal:  Clin Exp Immunol       Date:  2008-09       Impact factor: 4.330

Review 4.  X-linked agammaglobulinemia: lack of mature B lineage cells caused by mutations in the Btk kinase.

Authors:  C I Smith; C M Bäckesjö; A Berglöf; L J Brandén; T Islam; P T Mattsson; A J Mohamed; S Müller; B Nore; M Vihinen
Journal:  Springer Semin Immunopathol       Date:  1998

5.  Chronic bronchitis in immunocompromised patients: association with a novel Mycoplasma species.

Authors:  D Webster; H Windsor; C Ling; D Windsor; D Pitcher
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-08-26       Impact factor: 3.267

6.  Nontypeable Haemophilus influenzae: pathogenesis and prevention.

Authors:  A R Foxwell; J M Kyd; A W Cripps
Journal:  Microbiol Mol Biol Rev       Date:  1998-06       Impact factor: 11.056

7.  Phosphorylcholine allows for evasion of bactericidal antibody by Haemophilus influenzae.

Authors:  Sarah E Clark; Julian Snow; Jianjun Li; Tracey A Zola; Jeffrey N Weiser
Journal:  PLoS Pathog       Date:  2012-03-01       Impact factor: 6.823

Review 8.  The Lung Immune Response to Nontypeable Haemophilus influenzae (Lung Immunity to NTHi).

Authors:  Paul T King; Roleen Sharma
Journal:  J Immunol Res       Date:  2015-05-31       Impact factor: 4.818

9.  Antisera Against Certain Conserved Surface-Exposed Peptides of Nontypeable Haemophilus influenzae Are Protective.

Authors:  Paul W Whitby; Thomas W Seale; Daniel J Morton; Terrence L Stull
Journal:  PLoS One       Date:  2015-09-21       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.